Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exhausted intratumoral Vδ2- γδ T cells in human kidney cancer retain effector function. | Nat Immunol | 2023 | 36928415 | PubTator, text mining | PubMed |
| Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL-32/PRTN3 expression. | Cancer Sci | 2023 | 36919771 | PubTator, text mining | PubMed |
| Phenotypic diversity of human adipose tissue-resident NK cells in obesity. | Front Immunol | 2023 | 36911659 | PubTator, text mining | PubMed |
| Activation of immune signals during organ transplantation. | Signal Transduct Target Ther | 2023 | 36906586 | PubTator, text mining | PubMed |
The Influence of Maternal KIR Haplotype on the Reproductive Outcomes after Single Embryo Transfer in IVF Cycles in Patients with Recurrent Pregnancy Loss and Implantation Failure-A Single Center Experience. | J Clin Med | 2023 | 36902692 | PubTator, text mining | PubMed |
| Prognostic Value of EMT Gene Signature in Malignant Mesothelioma. | Int J Mol Sci | 2023 | 36901697 | PubTator, text mining | PubMed |
| The central role of natural killer cells in preeclampsia. | Front Immunol | 2023 | 36865565 | PubTator, text mining | PubMed |
| Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives. | Front Immunol | 2023 | 36865552 | PubTator, text mining | PubMed |
| Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire. | Front Immunol | 2023 | 36865545 | PubTator, text mining | PubMed |
| Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality. | NPJ Vaccines | 2023 | 36864042 | PubTator, text mining | PubMed |
| Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer. | Medicine (Baltimore) | 2023 | 36862902 | PubTator, text mining | PubMed |
| Effects of epigenetic therapy on natural killer cell function and development in hematologic malignancy. | J Leukoc Biol | 2023 | 36860165 | PubTator, text mining | PubMed |
| HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19. | Emerg Microbes Infect | 2023 | 36849422 | PubTator, text mining | PubMed |
| Recurrent Abortion and the Involvement of Killer-Cell Immunoglobulin-like Receptor (KIR) Genes, Activated T Cells, NK Abnormalities, and Cytokine Profiles. | J Clin Med | 2023 | 36835892 | PubTator, text mining | PubMed |
| A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome. | Cells | 2023 | 36831300 | PubTator, text mining | PubMed |
| Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. | Cancer Immunol Immunother | 2023 | 36823323 | PubTator, text mining | PubMed |
| KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. | J Immunother Cancer | 2023 | 36822669 | PubTator, text mining | PubMed |
| Mapping the interplay between NK cells and HIV: therapeutic implications. | J Leukoc Biol | 2023 | 36822173 | PubTator, text mining | PubMed |
| Genetic differences between smokers and never-smokers with lung cancer. | Front Immunol | 2023 | 36817482 | PubTator, text mining | PubMed |
| Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2023 | 36793272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=11